Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174760265> ?p ?o ?g. }
- W3174760265 endingPage "2690" @default.
- W3174760265 startingPage "2677" @default.
- W3174760265 abstract "2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphenol (UV 328; CAS: 25973-55-1) is an ultraviolet light (UV) absorber which belongs to the class of hydroxy phenol benzotriazoles. Therefore, UV 328 is added to plastics and other polymers due to its photostability to prevent discoloration and prolong product stability which may result in an exposure of consumers. However, information about the toxic effects on humans and the human metabolism are still lacking. In the present study, human metabolism pathways of UV 328 and its elimination kinetics were explored. For that purpose, three healthy volunteers were orally exposed to a single dose of 0.3 mg UV 328/kg bodyweight. UV 328 and its metabolites were investigated in blood and urine samples collected until 48 and 72 h after exposure, respectively. Thereby, previously published analytical procedures were applied for the sample analysis using dispersive liquid-liquid microextraction and subsequent measurement via gas chromatography coupled to tandem mass spectrometry with advanced electron ionization. UV 328 was found to be oxidized at its alkyl side chains leading to the formation of hydroxy and/or oxo function with maximum blood concentrations at 8-10 h after exposure for UV 328-6/3-OH, UV 328-4/3-OH and UV 328-4/3-CO. In contrast, a plateau for UV 328-4/3-CO-6/3-OH levels was reached around 10 h post-dosage. The highest blood levels were found for native UV 328 at 8 h after ingestion. Furthermore, biphasic elimination kinetics in blood were revealed for almost all detected metabolites. UV 328 and its metabolites did not occur in blood as conjugates. The renal elimination kinetics were very similar with the kinetics in blood. However, the prominence of the metabolites in urine was somewhat different compared to blood. In contrast, mostly conjugated metabolites occurred for renal elimination. In urine, UV 328-4/3-CO-6/3-OH was found to be the most dominant urinary biomarker followed by UV 328-6/3-OH and UV 328-4/3-OH. In total, approximately 0.1% of the orally administered dose was recovered in urine within 72 h. Although high levels of UV 328 in blood proved good resorption and high systemic availability of the substance in the human body, the urine results revealed a rather low quantitative metabolism and urinary excretion rate. Consequently, biliary excretion as part of the enterohepatic cycle and elimination via feces are assumed to be the preferred pathways instead of renal elimination." @default.
- W3174760265 created "2021-07-05" @default.
- W3174760265 creator A5018246294 @default.
- W3174760265 creator A5067685619 @default.
- W3174760265 creator A5077502969 @default.
- W3174760265 creator A5086262266 @default.
- W3174760265 date "2021-06-27" @default.
- W3174760265 modified "2023-09-25" @default.
- W3174760265 title "Human metabolism and kinetics of the UV absorber 2-(2H-benzotriazol-2-yl)-4,6-di-tert-pentylphenol (UV 328) after oral administration" @default.
- W3174760265 cites W1880589912 @default.
- W3174760265 cites W1966839189 @default.
- W3174760265 cites W1969628265 @default.
- W3174760265 cites W1984053406 @default.
- W3174760265 cites W1994316222 @default.
- W3174760265 cites W1998699580 @default.
- W3174760265 cites W1999506789 @default.
- W3174760265 cites W2023100415 @default.
- W3174760265 cites W2024677872 @default.
- W3174760265 cites W2033096355 @default.
- W3174760265 cites W2042449236 @default.
- W3174760265 cites W2045780645 @default.
- W3174760265 cites W2051191419 @default.
- W3174760265 cites W2055859302 @default.
- W3174760265 cites W2057134898 @default.
- W3174760265 cites W2082035778 @default.
- W3174760265 cites W2082454873 @default.
- W3174760265 cites W2086678865 @default.
- W3174760265 cites W2089257180 @default.
- W3174760265 cites W2090135915 @default.
- W3174760265 cites W2098989270 @default.
- W3174760265 cites W2108452302 @default.
- W3174760265 cites W2118663203 @default.
- W3174760265 cites W2119987138 @default.
- W3174760265 cites W2121842239 @default.
- W3174760265 cites W2139679342 @default.
- W3174760265 cites W2148089486 @default.
- W3174760265 cites W2261426935 @default.
- W3174760265 cites W2267648649 @default.
- W3174760265 cites W2317059325 @default.
- W3174760265 cites W2335483232 @default.
- W3174760265 cites W2347082974 @default.
- W3174760265 cites W2422269910 @default.
- W3174760265 cites W2483194402 @default.
- W3174760265 cites W2485391600 @default.
- W3174760265 cites W2497903025 @default.
- W3174760265 cites W2517406081 @default.
- W3174760265 cites W2530489738 @default.
- W3174760265 cites W2553723900 @default.
- W3174760265 cites W2554942703 @default.
- W3174760265 cites W2599526276 @default.
- W3174760265 cites W2706464883 @default.
- W3174760265 cites W2736991403 @default.
- W3174760265 cites W2781445155 @default.
- W3174760265 cites W2783767386 @default.
- W3174760265 cites W2883597738 @default.
- W3174760265 cites W2887304942 @default.
- W3174760265 cites W2888023996 @default.
- W3174760265 cites W2901697564 @default.
- W3174760265 cites W2914345664 @default.
- W3174760265 cites W2946177188 @default.
- W3174760265 cites W2952531772 @default.
- W3174760265 cites W2980916347 @default.
- W3174760265 cites W2991463267 @default.
- W3174760265 cites W3003390580 @default.
- W3174760265 cites W3004236001 @default.
- W3174760265 cites W3012103283 @default.
- W3174760265 cites W3030448702 @default.
- W3174760265 cites W3034088526 @default.
- W3174760265 cites W3042116505 @default.
- W3174760265 cites W3090829761 @default.
- W3174760265 cites W3112667934 @default.
- W3174760265 doi "https://doi.org/10.1007/s00204-021-03093-1" @default.
- W3174760265 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8298232" @default.
- W3174760265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34180011" @default.
- W3174760265 hasPublicationYear "2021" @default.
- W3174760265 type Work @default.
- W3174760265 sameAs 3174760265 @default.
- W3174760265 citedByCount "8" @default.
- W3174760265 countsByYear W31747602652022 @default.
- W3174760265 countsByYear W31747602652023 @default.
- W3174760265 crossrefType "journal-article" @default.
- W3174760265 hasAuthorship W3174760265A5018246294 @default.
- W3174760265 hasAuthorship W3174760265A5067685619 @default.
- W3174760265 hasAuthorship W3174760265A5077502969 @default.
- W3174760265 hasAuthorship W3174760265A5086262266 @default.
- W3174760265 hasBestOaLocation W31747602651 @default.
- W3174760265 hasConcept C121332964 @default.
- W3174760265 hasConcept C13965031 @default.
- W3174760265 hasConcept C148898269 @default.
- W3174760265 hasConcept C178790620 @default.
- W3174760265 hasConcept C185592680 @default.
- W3174760265 hasConcept C2776798109 @default.
- W3174760265 hasConcept C2777702071 @default.
- W3174760265 hasConcept C2780026642 @default.
- W3174760265 hasConcept C43617362 @default.
- W3174760265 hasConcept C55493867 @default.
- W3174760265 hasConcept C62231903 @default.
- W3174760265 hasConcept C62520636 @default.